dc.contributor.advisor | Delyuzar | |
dc.contributor.advisor | Laksmi, Lidya Imelda | |
dc.contributor.author | Siregar, M. Taufik | |
dc.date.accessioned | 2020-02-06T02:25:38Z | |
dc.date.available | 2020-02-06T02:25:38Z | |
dc.date.issued | 2019 | |
dc.identifier.uri | http://repositori.usu.ac.id/handle/123456789/23576 | |
dc.description.abstract | Background: Prostate disorders are one of the main causes of quality of life
disorders in men. Since 1994, the total PSA value has been approved by the
United States Food and Drug Administration (FDA) as a marker of early
detection, determining the stage and prognosis in prostate cancer. Many studies
have reported the benefits of tumor-infiltrating lymphocytes (TILs) in tumor cells,
where TILs are effective in slowing progression, although the mechanism is still
opposite .
Objective: To assess the correlation between the degrees of Stromal TILs with
Total PSA in BPH and Prostate Adenocarcinoma
Methods: 32 of histopathological slides of BPH and prostate adenocarcinoma
were examined to assess the degree of stromal TILs. Age characteristics and Total
PSA values were obtained through medical records. The relationship degree of
Stromal TILs with Total PSA was analyzed using SPSS version 22.
Results and Discussion: The results of analysis showed that there was a
significant correlation between the degree of stromal TILs and total PSA on BPH
and Prostate Adenocarcinoma. Inflammatory are commonly associated with
neoplasms, where TILs play a role as a tumor cell defense factor, which often
appears in solid tumors, including prostate. Reduce a number of inflammatory
cells in the prostate indicates a worse prognosis in prostate malignancy.
Conclusion: Percentage of stromal TILs and value of total PSA can be used to
determine prognostic factors in BPH and prostate adenocarcinoma. | en_US |
dc.description.abstract | Latar Belakang: Kelainan prostat merupakan salah satu penyebab utama dari
gangguan kualitas hidup pada laki-laki. Sejak tahun 1994, nilai Total PSA telah
disahkan oleh Food and Drug Administration (FDA) Amerika Serikat sebagai
marker deteksi dini, menentukan stadium dan prognosis pada kanker prostat.
Banyak penelitian yang melaporkan keuntungan Tumor Infiltrating Lymphocytes
(TILs) pada sel tumor, dimana TILs ini efektif untuk memperlambat progresi
tumor, meskipun mekanismenya masih berlawanan
Tujuan: Menilai hubungan derajat stromal Tumor Infiltrating Lymphocytes
(TILs) dengan total Prostate Specific Antigen (tPSA) pada BPH dan
Adenokarsinoma Prostat.
Metode: 32 slide histopatologi penderita BPH dan Adenokarsinoma Prostat
dinilai derajat stromal TILs nya. Nilai Total PSA didapatkan melalui rekam
medis. Hubungan derajat stromal Tumor Infiltrating Lymphocytes (TILs) dengan
total Prostate Specific Antigen (tPSA) dianalisis menggunakan SPSS versi 22.
Hasil dan Diskusi: Terdapat hubungan yang signifikan antara derajat stromal
Tumor Infiltrating Lymphocytes (TILs) dan total Prostate Spesific Antigen (tPSA)
pada BPH dan Adenokarsinoma Prostat, dimana menurunnya derajat stromal TILs
diikuti oleh peningkatan nilai total PSA. Sel inflamasi umumnya berkaitan dengan
neoplasma, dimana limfosit berperan sebagai faktor pertahanan sel tumor, yang
sering muncul pada tumor solid, termasuk prostat. Berkurangnya jumlah sel
radang pada prostat menunjukkan prognosis yang lebih buruk pada keganasan
prostat.
Simpulan: Penilaian stromal TILs dan total PSA dapat digunakan untuk
menentukan faktor prognosis pada BPH dan Adenokarsinoma Prostat. | en_US |
dc.language.iso | id | en_US |
dc.publisher | Universitas Sumatera Utara | en_US |
dc.subject | Benign Prostate Hyperplasia | en_US |
dc.subject | Adenokarsinoma Prostat | en_US |
dc.subject | Stromal TILs | en_US |
dc.subject | Total PSA | en_US |
dc.title | Hubungan Derajat Stromal Tumor Infiltrating Lymphocytes (TILs) dengan Total Prostate Specific Antigen (tPSA) pada Benign Prostate Hyperplasia (BPH) dan Adenokarsinoma Prostat | en_US |
dc.type | Thesis | en_US |
dc.identifier.nim | NIM167041038 | |
dc.description.pages | 86 Halaman | en_US |
dc.description.type | Skripsi Sarjana | en_US |